Rna

Edit

Strategic Insights into RNA Therapy: Adapting to Regulatory Changes and Supply Chain Shifts for Sustained Growth

Nasdaq Globe Newswire 16 Jan 2026

The RNA therapy market presents opportunities in innovative RNA modalities, personalized medicine demand, and strategic partnerships.

Edit

Gene-Based RNA "Vaccines" Have Been Used in Our Food Supply Since 2012

Sott 16 Jan 2026

SEQUIVITY is marketed as an "RNA particle" vaccine system designed to deliver genetic instructions so the animal's cells produce targeted antigens ... ....

Edit

Scientists transform enigmatic cell structures into devices for recording RNA activity

Phys Dot Org 16 Jan 2026

Scientists can peer into cells to get a limited view of their activity using microscopes and other tools ... ....

Edit

RNA Sequencing Services Market by Type of Sequencing Method, Application Area, End User Industry and ...

Business Wire 15 Jan 2026

DUBLIN--(BUSINESS WIRE)--The "RNA Sequencing Service Market ... The RNA sequencing service market is ...

Edit

Tiny RNA molecules in sperm can have big impact on health of babies

Phys Dot Org 13 Jan 2026

....

Edit

$7.5 Billion RNA Sequencing Services Market Opportunity Outlook, 2035

Nasdaq Globe Newswire 12 Jan 2026

Key opportunities lie in next-generation sequencing ...

Edit

Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio (Form 8-K) (Wave Life Sciences Ltd)

Public Technologies 12 Jan 2026

Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio ... "At Wave, we are using our novel chemistry to translate powerful human genetic insights into potentially transformational RNA medicines.

Edit

Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio (Wave Life Sciences Ltd)

Public Technologies 12 Jan 2026

Extending leadership in RNA editing following ... "At Wave, we are using our novel chemistry to translate powerful human genetic insights into potentially transformational RNA medicines ... RNA editing.

Edit

ADAR-GPT: A continually fine-tuned language model for predicting A-to-I RNA editing sites

PNAS 09 Jan 2026

SignificanceA-to-I RNA editing by adenosine deaminases acting on RNA ...

Edit

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular ...

Nasdaq Globe Newswire 08 Jan 2026

Entrada Therapeutics reports progress across its portfolio of RNA-based programs for the potential treatment of neuromuscular and ocular diseases ... .

Edit

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the

The Eagle-Tribune 08 Jan 2026

-- Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 – ... .

Edit

Acuitas Therapeutics Expands Collaboration with RNA Technologies & Therapeutics Through Strategic Investment

Business Wire 08 Jan 2026

VANCOUVER, British Columbia--(BUSINESS WIRE)--The investment will expand RNA T&T's operations and allow partners of both companies to leverage combined expertise in RNA-LNP therapeutics ... .

Edit

STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications (IP Group plc)

Public Technologies 08 Jan 2026

(STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida Biosciences Inc ... RNA regulation.

Edit

Detecting and Characterizing RNA Drug Candidates to Accelerate Therapeutic Development, Upcoming Webinar Hosted by Xtalks

PR Newswire 08 Jan 2026

Attendees will learn approaches for mapping small RNA-target interactions across the transcriptome. The featured speakers will share how combined localization and functional assays create an end-to-end view of RNA therapeutic behavior.

Edit

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases (Form 8-K) (Entrada Therapeutics Inc)

Public Technologies 08 Jan 2026

) Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases.

Podcasts:

Latest News for: rna

Strategic Insights into RNA Therapy: Adapting to Regulatory Changes and Supply Chain Shifts for Sustained Growth

Gene-Based RNA "Vaccines" Have Been Used in Our Food Supply Since 2012

Scientists transform enigmatic cell structures into devices for recording RNA activity

RNA Sequencing Services Market by Type of Sequencing Method, Application Area, End User Industry and ...

Tiny RNA molecules in sperm can have big impact on health of babies

$7.5 Billion RNA Sequencing Services Market Opportunity Outlook, 2035

Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio (Form 8-K) (Wave Life Sciences Ltd)

Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio (Wave Life Sciences Ltd)

ADAR-GPT: A continually fine-tuned language model for predicting A-to-I RNA editing sites

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular ...

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the

Acuitas Therapeutics Expands Collaboration with RNA Technologies & Therapeutics Through Strategic Investment

STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications (IP Group plc)

Detecting and Characterizing RNA Drug Candidates to Accelerate Therapeutic Development, Upcoming Webinar Hosted by Xtalks

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases (Form 8-K) (Entrada Therapeutics Inc)

Article Search

EXPLORE WN.com